Immune

KPV

Mechanism

Tripeptide (Lys-Pro-Val) derived from the C-terminus of alpha-melanocyte-stimulating hormone. Inhibits NF-kB pathway and reduces pro-inflammatory cytokine signalling. Active orally with intact absorption (unlike most peptides). Strong evidence in IBD/colitis models.

Typical dose

200-500mcg per dose, 1-2 times daily

Cycle length

4-12 weeks per condition

Form

Oral capsules, injectable (subcutaneous)

Deep dives on KPV

What the FDA Reclassification Actually Means for Peptide UsersFDA peptide reclassification 2026: what Category 2 to Category 1 actually means for users, what's changed, what hasn't, and what to expect from the July PCAC meeting.
7 Best Peptides for Injury Recovery (2026 Guide)The 7 best peptides for injury recovery ranked by evidence and practical use. Covers BPC-157, TB-500, the Wolverine Stack, GHK-Cu, CJC-1295/Ipamorelin, Thymosin Alpha-1, and KPV with protocols and stacking guidance.
Which Peptides Are Legal Again in 2026? The Full FDA ListComplete guide to the 14 peptides returning to legal compounding status in 2026 after RFK Jr.'s FDA reclassification announcement. Every compound explained.

Get the Pre-Protocol Checklist

Free checklist plus weekly protocols, research breakdowns, and tactical guides. No spam. Unsubscribe anytime.